CHILDS JOHN W 4/A

What Happened
John W. Childs, a director of Biohaven Ltd. (BHVN), indirectly acquired 28,400 common shares through the John W Childs 2013 Revocable Trust in an open-market purchase on March 4, 2025. The total reported value is approximately $864,115 based on a weighted average price of $30.43 per share. This filing is an amendment correcting how the indirect ownership was reported in the original Form 4.

Key Details

• Transaction type: Purchase (Code P) — open market / private purchase reported indirectly via the John W Childs 2013 Revocable Trust.
• Transaction date: March 4, 2025. Weighted average price reported: $30.43 per share; total value ≈ $864,115.
• Price range: purchases occurred at prices from $30.17 to $30.89 (footnote states full breakdown available upon request).
• Shares owned after transaction: Not specified in this amendment.
• Filing status: This is an AMENDED Form 4. The original Form 4 was filed March 5, 2025; this amendment (filed March 9, 2026) corrects the indirect ownership reporting (all 28,400 shares are via the revocable trust; none via the 2013 Charitable Remainder Trust).

Context

• Purchase signals: Purchases by directors can be viewed as a stronger signal than sales, but filings only show the transaction — they do not state motive.
• Indirect ownership: Because the shares were acquired indirectly through a revocable trust, beneficial ownership is via the trust rather than a direct personal purchase.
• Amendment note: The amendment corrects which entity held the indirect interest; it does not change the number of shares or the purchase prices reported.